DIETARY FIBERS IN THE CORRECTION OF DYSLIPIDEMIA IN PATIENTS WITH HEPATIC STEATOSIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives information on the value of dietary fibers for the correction of metabolic syndrome (MS) manifestations. The author describes her own experience with a dietary fiber medicine (Mucofalk) in patients with MS, hepatic steatosis, and lipid metabolic disturbance.

Full Text

Restricted Access

About the authors

E. Professor

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: golovanovaev@mail.ru
Professor, MD Central Research Institute of Gastroenterology

References

  1. Голованова Е.В. Тиогамма при неалкогольной жировой болезни печени // Фарматека. - 2012; 7 (240): 53-7.
  2. Голованова Е.В., Ковязина И.О., Шапошникова Н.А. Рациональная фармакотерапия неалкогольного стеатогепатита. // Вестн. семейной медицины. -2010; 2: 54-9.
  3. Драпкина O.M., Смирин В.И., Ивашкин B.T. Патогенез, лечение и эпидемиология НАЖБП - что нового? Эпидемиология НАЖБП в России // РМЖ. -2011; 28: 1717-21.
  4. Лазебник Л.Б., Голованова Е.В., Ковязина И.О. и др. Эссенциальные фосфолипиды в терапии неалкогольных стеатогепатитов // Consilium Medicum. - 2007; 9 (7): 23-8.
  5. Чиркин В.И., Лазарев И.А., Ардатская М.Д. Долгосрочные эффекты препарата пищевых волокон псиллиума (Мукофальк) у пациентов с метаболическим синдромом // Клин. перспективы в гастроэнтерол., гепатол. - 2012; 1: 34-42.
  6. Abel E. Moreyra, Alan C. et al. Effekt of Combining Psyllium Fiber With Simvastatin in Lowering Cholesterol // Apch Intern. Med. - 2005; 165: 1161-6.
  7. Anderson J. et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men // Arch. Intern. Med. - 1988; 148 (2): 292-6.
  8. Anderson J. et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials // Am. J. Clin. Nutr. - 2000; 71 (2): 472-9.
  9. Dongiovanni P., Valenti L., Rametta R. et al. Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease // Gut. - 2010; 59: 267-73.
  10. Judith A. Marlett, Milton H. Fischer The active fraction of psyllium seed husk // Proceedings of the Nutrition Society. - 2003; 62: 207-9.
  11. Kleiner D., Brunt E., Van Natta M. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease // Hepatology. -2005; 41: 1313-21.
  12. Leuschner U., James O., Dancygier H. Steatohepatitis / NASH and ASH: Springer, 2004; р. 35.
  13. Loos R., Savage D. Inherited susceptibility to non-alcoholic fatty liver disease // Diabetologia. - 2009; 52: 1000-2.
  14. Oliveira Claudia Pinto Marques Souza, Stefano Jose Tadeu, Ana Mercedes Cavaleiro Ana Mercedes et al. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease // J. Gastroenterol. Hepatol. - 2010; 25: 357-61.
  15. Powell et al.; Lee et al.; Bacon et al.; Falk-Ytter et al.
  16. Zheng Lin, Lv Guo-cai, Sheng Jifang, Yang Yi-da. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD // J. Gastroenterol. Hepatol. - 2010; 25: 156-63.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House